Streptococcus salivarius M18 and Reduced Oral Pathogenic Bacteria Count

• Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study

  • 2020-08-06
  • RCT · n = 13
  • Scientific Reports 10(1)
  • • A. Vesty
    • K. Gear
    • Sharon Boutell
    • Michael W Taylor
    • R. Douglas
    • K. Biswas

  • PubMed: 32764634
  • DOI: 10.1038/s41598-020-70024-y

  3 Insights on

  • Reduced Oral Pathogenic Bacteria Count

  • High evidence
  • Rigorous Journal

  The oral probiotic lozenges did not significantly impact bacterial community composition or diversity, nor did the probiotic lozenges increase the relative sequence abundance of ZOTU_1

  Effect

  Neutral

  Effect size

  Small

  Significant

  No